Residual or recurrent laryngeal cancer after irradiation is a difficult clinical problem with a rate that ranges from 13% to 36% of cases. Supracricoid laryngectomy (SCL) with cricohyoidopexy (CHP) or cricohyoidoepiglottopexy (CHEP) provide reliable oncological and functional results for selected primary and recurrent patients with glottic and supraglottic carcinomas. We conducted a systematic review and meta-analysis to assess the oncological and functional outcomes of patients treated with open partial horizontal laryngectomy types IIa and IIb (CHEP, CHP) in terms of the recurrence of squamocellular cancer of the larynx after radiotherapy failure. The databases searched included MEDLINE, PubMed and EMBASE (from January 1990 to December 2015, English language). The meta-analysis was performed with a mixed random effects model using the DerSimonian and Laird method. The heterogeneity was measured with the I 2 statistic. Fourteen papers out of 276 were included and comprised a total of 291 patients. The five-year overall survival was 80.2% (CI 0.719-0.885; I 2 = 62%; p = 0.003), and the 5-year disease-free survival was 89.5% (CI 0.838-0.952; I 2 = 52%; p = 0.022). The indications for SCL after the failure of radiation therapy (RT) were similar to those specified for previously untreated patients. We therefore hypothesised that careful assessment of tumour extension might be responsible for the high 5-year OS and 5-year DFS. The early postoperative recovery outcomes indicated that the mean time until decannulation was 35.6 days (CI 24.3-46.9; I 2 = 95%; p < 0.001), and the mean time until nasogastric tube (NGT) or percutaneous endoscopic gastrostomy (PEG) removal was 28.3 days (CI 22.7-33.8; I 2 = 86%; p< = 0.001). These data are according to authors who prefer the initial removal of the NGT and the initiation of oral alimentation with a tracheostomy tube to protect and clean the airways and permit the suction of any residual food that might be present. 35, 6 giorni (IC 24, 9; I 2 = 95%; p < 0,001), mentre il tempo medio di rimozione del sondino naso-gastrico (SNG) o della gastrostrostomia percutanea endoscopica (PEG) è stato di 28,3 giorni (IC 22, 8; I 2 = 86%; p <= 0.001). Questi dati sono in accordo con gli Autori che preferiscono la rimozione precoce del sondino nasogastrico. In tal modo si può riprendere l'alimentazione orale quando è ancora presente il tubo endotracheale a protezione delle vie aree e permettere l'aspirazione degli eventuali residui alimentari. 
Introduction
Residual or recurrent laryngeal cancer after irradiation is a difficult clinical problem with a rate that ranges from 13% to 36% [1] [2] [3] [4] . Although several treatment options exist for patients affected with laryngeal cancer at first presentation 5 6 , the options for those with recurrent cancer are limited based on the initial treatment received 7 . Cancers that recur after radiation therapy (RT) often exhibit aggressive behaviour, arise in a field in which lymphatic drainage is unpredictable and are associated with poor control rates 8 . Total laryngectomy is a frequently recommended option even for early recurrent cancers after chemoradiotherapy, but this procedure substantially impairs the quality of life primarily due to the permanent tracheostoma and the loss of the voice 9 . Supracricoid laryngectomies (SCLs) were recently classified by the European Laryngological Society 10 as Open Partial Horizontal Laryngectomies Type II, which include reconstructions either by cricohyoidoepiglottopexy (CHEP; renamed OPHL Type IIa) or cricohyoidopexy (CHP; renamed OPHL Type IIb). Both of these procedures provide reliable oncological and functional results for selected primary and recurrent patients with glottic and supraglottic carcinomas [11] [12] [13] [14] . Several reports regarding the effectiveness of SCLs in terms of survival and functional results considering residual and recurrent cancer have been published. The aim of this systematic review and meta-analysis was to evaluate the pooled oncological and short-term postoperative recovery outcomes of supracricoid laryngectomies with CHEP and CHP in the setting of recurrent laryngeal squamocellular cancer (SCC) after chemoradiotherapy.
Materials and methods

Data sources and searches
We aimed to identify all papers that assessed the oncological and functional outcomes of patients treated with supracricoid laryngectomy for recurrence of SCC of the larynx after RT failure. The databases searched included MEDLINE, PubMed and EMBASE (from January 1990 to December 2015). We applied English language and abstract availability restrictions. Our search included the following keywords: laryngeal cancer, supracricoid laryngectomies, subtotal laryngectomy, cricohyoidopexy, cricohyoidoepiglottopexy, and/or retrospective study, prospective and randomised clinical study.
Selection of studies
Publications were included if they included patients affected with recurrent laryngeal SCC after initial treatment with RT that was salvaged with supracricoid laryngectomy and reported the 5-year overall survival (OS), 5-year disease free survival (DFS) and short-term postoperative recovery outcomes.
We included only full published papers and excluded abstracts and reviews. Papers containing inadequately separable oncological or functional data, series that included patients treated with different procedures and those focusing on other topics or other surgical techniques were excluded.
Outcome measures
The primary outcome was 5-year overall survival (OS). The secondary outcomes were 5-year disease-free survival (DFS), short-term postoperative recovery outcomes and 5-year OS and 5-year DFS according to the T stage (early and locally advanced). Short-term postoperative recovery outcomes included the mean time until decannulation and the mean time required for oral feeding restoration, which is expressed as the mean time until nasogastric tube (NGT) or percutaneous endoscopic gastrostomy (PEG) removal. According to T stage, patients were divided into two groups for statistical analysis, i.e., early (rT1-T2) and locally advanced (rT3-T4) groups.
Data extraction
Initial selection was performed via the screening of the titles and abstracts by two pairs of independent reviewers (GR and CAL, PC and DT). For detailed evaluations, fulltext copies of all studies except one (Shenoy et al., 2000) that were possibly relevant were obtained. The data from each study were extracted independently by paired and independent reviewers (GR and CAL, PC and DT) using a pre-standardised data abstraction form. The data extracted from the publications were independently checked for accuracy by two additional reviewers (PC and PD). We resolved any possible disagreements by consensus in consultation with a third reviewer (CAL) when needed.
Quantitative analysis
The meta-analysis was performed with a mixed random effect model using the DerSimonian and Laird method. The results were graphically represented using Forest plots. The proportions and 95% CIs for each outcome were separately calculated for each trial with the grouped data using the intention-to-treat principle. The choice to use the proportions was driven by the design of meta-analysis, which was based on the included studies. The tau 2 was used to define the between-studies variance. The P value was set at 0.05. The homogeneity assumption was examined with the Q test with a degree of freedom (df) equal to the number of analysed studies minus 1. The heterogeneity was measured with the I 2 statistic, which describes the percentage of total variation across studies that is due to heterogeneity rather than chance. The I 2 was calculated from the basic results obtained from a typical meta-analysis as I 2 = 100% Å ~ (Q − df)/Q, where Q is Cochran's heterogeneity statistic, and df is the degrees of freedom. A value of 0% indicates no observed heteroge-neity, and larger values indicate increasing heterogeneity. We performed an "a priori" sub-analysis of the oncological outcomes according to the early (rT1-T2) and locally advanced (rT3-T4) stages of recurrent laryngeal SCC. Next, we performed an "a priori" comparison of the same oncological outcomes between early (rT1-T2) and locally advanced (rT3-T4) stages of recurrent laryngeal SCC. For comparisons, we performed the meta-analyses with the odds ratios (ORs), and 2-sided p-values < 0.05 were considered significant. The analyses were conducted with OpenMetaAnalyst (version 6) and SPSS version 20 (IBM SPSS). To evaluate potential publication bias, we used a weighted linear regression and a modified Macaskill's test, which provides more balanced type I error rates in the tail probability areas relative to other publication bias tests 15 . GR conducted the statistical analyses.
Limitations
This systematic review and meta-analysis has some limitations that need to be addressed. We included only full papers in the English language and excluded abstracts. Moreover, all of the included studies were retrospective. We observed substantial heterogeneity (I 2 > 50%) according to the Cochrane guidelines in 4 of 10 outcomes considered.
Results
Study selection
We identified 276 references. One hundred eight-seven papers were excluded after reading the titles, and 70 were excluded after reading the abstracts. We analysed 19 retrospective studies in full paper format because no prospective or randomised studies were found. Fourteen references including 291 patients fulfilled our search criteria 7 9 13 16-18 20-25 27 28 . Six of these studies involved mixed series 7 9 16 17 22 23 because they included patients who underwent primary SCL and salvage SCL after RT failure. The remaining eight papers focused only on salvage surgeries. Five references were excluded, including 3 mixed series whose authors 12 19 29 reported only the cumulative data for the series, one paper 30 that was not available and one 26 study that included other surgical techniques. Figure 1 illustrates the study selection process.
Characteristics of studies included
The 14 papers included 291 adult patients. The 5-year OS and 5-year DFS were reported in all papers with the exceptions of Farrag et al.
22
, Pellini et al. 23 and de Vincentiis 7 . For the papers of Sperry et al. 16 , Nakayama et al. 17 , Deganello et al. 20 , Leon et al. 21 and Marchese-Ragona et al. 27 , it was possible to extract these data from the text. All papers with the exceptions of Leone et al. 9 and Nakayama et al. 17 reported the short-term post-operative recovery outcomes, and Sperry et al. 16 and Pellini et al. 23 reported only the cumulative data for their series. The main characteristics of the studies included are reported in Table I .
Definitions of oncological and functional outcomes
The oncological outcomes were calculated from the date of surgery. The endpoint for OS was the date of death regardless of cause, whereas the endpoint for DFS was date of recurrence (local, locoregional or metastatic). For the evaluations of short-term postoperative recovery, the outcomes included the mean time until decannulation and the mean time until NGT or PEG removal.
Primary outcome
The 5-year OS was 80.2% (CI 0.719-0.885; I 2 = 62%; p = 0.003), and the corresponding Forest plot is shown in Figure 2 . We identified 276 references. One hundred eight-seven papers were excluded after reading the title, and 70 were excluded after reading the abstracts. We analysed 19 retrospective studies in full paper format. Fourteen references including 291 patients fulfilled our search criteria. Five references were excluded, including 3 mixed series whose authors reported only the cumulative data of the series, one paper that was not available and one that included other surgical techniques. 
Secondary outcomes
The 5-year DFS was 89.5% (CI 0.838-0.952; I 2 = 52%; p = 0.022) as illustrated in Figure 4 . Figure 6 . The mean time until NGT or PEG removal was 28.3 days (CI 22.7-33.8; I 2 = 86%; p <= 0.001; Fig. 7 ).
Publication bias
No publication bias was detected according to Macaskill's modified test.
Discussion
In most centres in northern Europe and North America, radiotherapy is the primary treatment for patients with early laryngeal SCC 32 . RT is a well-established treatment for selected laryngeal carcinomas that elicits good oncologic and functional results. The reported failure rates range between 9-21% for T1 and 28-37% for T2 glottic carcinomas. In supraglottic laryngeal cancer, the reported failure rates for T1 and T2 lesions are 24-30% and 25%-45%, respectively 33 . Re-irradiation protocols (in combination with radio-sensitising agents) are at significant risk for morbidity 34 35 and remain investigational; they may be considered for patients with unresectable locoregional disease. Therefore, surgery is the preferred modality for curative treatment of recurrent laryngeal cancer after failure of nonsurgical treatments. There are three options for salvage surgery after radiation failure: total laryngectomy, transoral laser microsurgery (TLM) and open partial laryngectomy. Total laryngectomy is widely considered the classic approach to glottic SCC recurrence after irradiation 36 , but considerably impairs the quality of life primarily due to the permanent tracheostoma and the loss of voice 9 . Compared with alternative treatment options for laryngeal cancer, the oncological outcomes of TLM are inferior to those of open partial laryngectomy. TLM has a relatively lower mean larynx preservation rate of 72.3% versus 84% for open partial laryngectomy, which reflects a higher locoregional failure rate after TLM 8 . In the radio-recurrent setting, open partial laryngectomies have been less commonly used in the past due to concerns about unpredictable spreading and the postoperative function of the irradiated organ as well as a higher risk of complications 8 . The correct assessment of tumour extension of a recurrent laryngeal carcinoma may be difficult due to the residual inflammatory or functional changes associated with radiation therapy. Many recurrences present with multicentric tumour foci that are localised below intact mucosa and further masked by post-treatment oedema and fibrosis 37 . This pathological phenomenon that results in clinically significant difficulties in correctly restaging the tumour after irradiation justify the classical choice of salvage total laryngectomy in cases of carcinoma recurrence fol- lowing radiotherapy failure 29 . There have been several reports about the effectiveness of open partial laryngectomies in terms of survival and functional results in residual or recurrent cancer. To our knowledge, this is first systematic review and meta-analysis to examine the oncological outcomes according to T stage and short-term postoperative recovery outcomes of SCL for treatment of laryngeal SCC after RT failure. This systematic review and meta-analysis resulted in the following findings: 1) 5-year OS was 80.2%; 2) 5-year DFS was 89.5%; 3) mean time until decannulation was 35.6 days; and 4) mean time until NGT or PEG removal was 28.3 days. The studies included in this meta-analysis share a common trait, i.e., the strict criteria for patient selection for candidacy for SCL after RT failure 9 . The indications and contraindications after the failure of RT are similar to those that have been specified for patients with previously untreated laryngeal tumours 30 . Therefore, we hypothesise that careful assessment of tumour extension might be responsible for the high 5-year OS and 5-year DFS. In our sub-analysis, we found that 5-year OS for T1-T2 patients (early stage) was 79.8%; interestingly, this rate was 92.3% for T3-T4 patients (locally advanced stage). The 5-year DFS was 86.9% for T1-T2 patients and 91.1% for T3-T4 patients. These data might be attributable to inaccurate staging (i.e., understaging) prior to salvage surgery. In this regard, Zbaren et al. 37 reported that 52% of patients were clinically understaged and that the diagnostic accuracy of clinical evaluation (via fiberoptic laryngoscopy, CT, MRI, or microlaryngoscopic examination findings) was only 38%. Nevertheless, our statistical analysis demonstrated that the differences between the 5-year OS and DFS of early and locally advanced SCC patients were not significantly different (p = 0.340 and p = 0.841, respectively). However, these results may have been influenced by the small size of the locally advanced stage group (only 17 patients). Some of the papers included in this meta-analysis 9 16 23-25 27 reported only clinical TNM. We strongly believe that future studies should also report pathological stage after salvage surgery. The theoretical advantage of SCL over TL is that at least one functioning crico-arytenoid joint is maintained, and thus a permanent tracheostoma is not required, and the main laryngeal functions (i.e., respiration, phonation and swallowing) are preserved. Nevertheless, swallowing impairment represents the main functional issue due to the modification of the hypopharyngo/laryngeal anatomy. This condition has implications for the quality of life in addition to an association with potentially life threatening complications, such as aspiration pneumonia 38 39 . This meta-analysis demonstrated that the mean time until NGT or PEG removal was 28.3 days, and the mean time until decannulation was 35.6 days. These data accord with the reports of other authors 40 41 who prefer the initial removal of the NGT and initiation of oral alimentation with a tracheostomy tube to protect and clean the airways and permit the suction of any residual food that may be present 13 . However, the proper postoperative management of tracheostomies is still under debate. In contrast, different authors 28 29 42-56 have proposed early removal of the tracheostomy tube to ensure a rapid mobilisation of the residual larynx to avoid any interference with the cough reflex, which limits the incidence of pulmonary infection 13 . These different approaches might be due to personal experience or the preferences of the surgeon. Some authors 27 36 have suggested that, in consideration of the possibility of long-lasting swallowing disorders, clinicians should consider preoperative PEG in patients undergoing SCL as a salvage surgery for glottic carcinoma after irradiation failure. This suggestion is consistent with the opinion of the majority of the authors of the studies included in the present meta-analysis 13 16 18 22 25 27 28 . SCLs allow for satisfactory functional results, but surgical protocols need to be followed by adequate nursing and rehabilitation protocols. However, there is no evidence regarding when rehabilitation should be initiated, which criteria should be adopted to indicate the initiation and termination of rehabilitation, or which voice and swallowing rehabilitation procedures provide the optimal functional outcomes 57 . Therefore, we recommend that future work should focus on standardising postoperative care and rehabilitation protocols. 
Conclusions
Recurrent laryngeal cancer after irradiation is a difficult clinical problem. Although total laryngectomy has been widely considered for many years to be the treatment of choice, this meta-analysis demonstrated that supracricoid laryngectomy for recurrent laryngeal cancer after chemoradiotherapy provides reliable oncological and short-term postoperative recovery outcomes. 
